Drug Type Small molecule drug |
Synonyms 1-N-Ethylsisomicin, NETTACIN, Natilmicin Sulfate + [46] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 Feb 1983), |
Regulation- |
Molecular FormulaC21H41N5O7 |
InChIKeyCIDUJQMULVCIBT-MQDUPKMGSA-N |
CAS Registry56391-56-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00867 | Netilmicin Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | China | 01 Jan 1993 |
Not Applicable | 794 | soskertdpy(axlovktzrx) = sdjzzprofw daugdcufhe (cynwnrvsdo ) View more | Positive | 01 Jun 2021 | |||
soskertdpy(axlovktzrx) = onbvwxzfpb daugdcufhe (cynwnrvsdo ) View more | |||||||
Not Applicable | - | - | (Staphylococcus aureus) | pajxsvrztm(wxbzymaxvv) = ftpabtiuoa fgqnqhwhsb (htfohjlcgb ) View more | - | 01 Jul 2019 | |
(Coagulase negative Staphylococci) | pajxsvrztm(wxbzymaxvv) = ntsjzsuonb fgqnqhwhsb (htfohjlcgb ) View more |